Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mokelumne river	6/18/2015 4:48:57 PM
	Read Replies (2) of 2026

Somewhat off topic, I have been curious as to where our Board Chair is going to land after he stepped down as CEO of Regulus. The current Apricus bio lists him as a "serial entrepreneur." "Dr. Xanthopoulos is currently a Principal at the Vandel-Group focusing on investing and building innovative biotechnology companies." I can't find anything else on the Vandel-Group other than its CEO is a Marios Fotiadis. One thing for certain, wherever he has been including his current engagements, they all have a decided Helenic flavor in terms of his associates. Many of them, including Xanthopoulos, have last names as long as mine, all of which I can easily pronounce. : )

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next